SCYX (STOCKS)
SCYNEXIS, Inc.
$0.799800
-0.011300 (-1.39%)
Prev close: $0.811100
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Angulo Gonzalez
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $36.04M
- Employees
- 29
- P/E (TTM)
- -1.51
- P/B (TTM)
- 0.93
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $2.93M |
| Benefits Costs and Expenses | $28.21M |
| Costs And Expenses | $28.21M |
| Nonoperating Income/Loss | $9.37M |
| Operating Expenses | $37.58M |
| Selling, General, and Administrative Expenses | $15.53M |
| Research and Development | $22.05M |
| Operating Income/Loss | -$34.65M |
| Income/Loss From Continuing Operations After Tax | -$25.30M |
| Income/Loss From Continuing Operations Before Tax | -$25.28M |
| Income Tax Expense/Benefit | $23.00K |
| Net Income/Loss | -$25.30M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$25.30M |
| Net Income/Loss Available To Common Stockholders, Basic | -$25.30M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.51 |
| Diluted Earnings Per Share | -$0.51 |
| Basic Average Shares | 49,750,315 |
| Diluted Average Shares | 49,750,315 |
| Assets | $51.07M |
| Current Assets | $48.69M |
| Cash | $37.90M |
| Other Current Assets | $10.79M |
| Noncurrent Assets | $2.38M |
| Liabilities | $14.64M |
| Current Liabilities | $8.47M |
| Accounts Payable | $3.47M |
| Other Current Liabilities | $5.00M |
| Noncurrent Liabilities | $6.17M |
| Equity | $36.43M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $36.43M |
| Liabilities And Equity | $51.07M |
| Net Cash Flow From Operating Activities | -$33.59M |
| Net Cash Flow From Operating Activities, Continuing | -$33.59M |
| Net Cash Flow From Investing Activities | $33.51M |
| Net Cash Flow From Investing Activities, Continuing | $33.51M |
| Net Cash Flow From Financing Activities | -$14.21M |
| Net Cash Flow From Financing Activities, Continuing | -$14.21M |
| Net Cash Flow | -$14.29M |
| Net Cash Flow, Continuing | -$14.29M |
| Comprehensive Income/Loss | -$25.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$25.30M |
| Other Comprehensive Income/Loss | $0.00 |